Cite
Exploring the mechanism of dendrobine in treating metabolic associated fatty liver disease based on network pharmacology and experimental validation.
MLA
Li, Feng, et al. “Exploring the Mechanism of Dendrobine in Treating Metabolic Associated Fatty Liver Disease Based on Network Pharmacology and Experimental Validation.” Hereditas, vol. 161, no. 1, May 2024, pp. 1–18. EBSCOhost, https://doi.org/10.1186/s41065-024-00322-2.
APA
Li, F., Wu, J., Zhu, Y., Zhang, X., Wang, M., & Zhou, S. (2024). Exploring the mechanism of dendrobine in treating metabolic associated fatty liver disease based on network pharmacology and experimental validation. Hereditas, 161(1), 1–18. https://doi.org/10.1186/s41065-024-00322-2
Chicago
Li, Feng, Jialin Wu, Ye Zhu, Xiaoyan Zhang, Miao Wang, and Shigao Zhou. 2024. “Exploring the Mechanism of Dendrobine in Treating Metabolic Associated Fatty Liver Disease Based on Network Pharmacology and Experimental Validation.” Hereditas 161 (1): 1–18. doi:10.1186/s41065-024-00322-2.